{"ok":true,"trend":{"id":94250,"platform":"news","region":"global","key":"eli lilly ceo bets on weight-loss medicine retatrutide as next growth driver, says firm’s future has ‘never been brighter’","title":"Eli Lilly CEO Bets On Weight-Loss Medicine Retatrutide As Next Growth Driver, Says Firm’s Future Has ‘Never Been Brighter’","url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNQ2YwUXdHYjhqV2hkZFBKTFhDSk9BOVlLTXBBSXpKRU8wZndKb0ZkcGIzMTN4ckdoQWJnS282MHRNS1NLdFhBVHB5TVZXU0FEa3QzemFDNzNXNEozZnkzbUtnbDRVNFBuSkI0WDUxbU1GYWx6YVdENXN3aWZyeGVVcno1dWx2WVNlcVEtUGVvVng4Y3ZxSmprZ2xBRnltRFg2MlFuREFHeFZLYUl2Y0g2WHlFcHdmNk90UjM1bGhlNmlVcGJTTTZ5eWlPSFdJNVVxZHY2b3A0Z28tOGdNVUF3SnBhZ1ZGMUxBS2N1R05yc1ZHM0w2UndTYUpUNG5LNUUtbzdjb3lTM0ZlQWh3RGc?oc=5","first_seen":"2026-09-27T09:56:46.513038Z","last_seen":"2026-09-27T12:40:46.043478Z","last_rank":25,"peak_rank":16,"last_volume":null,"peak_volume":0,"seen_count":3,"score":29.29,"category_hint":"medicine","section":"health","category":"medicine","summary":"Eli Lilly's chief executive said the company's future has 'never been brighter' as it positions retatrutide, its experimental weight-loss and diabetes drug, as the next major growth driver. The statement follows strong investor interest in Lilly's obesity pipeline, which already includes the blockbuster tirzepatide. Retatrutide is in late-stage trials and is viewed as a potential rival to next-generation obesity treatments. Markets are watching closely as competition in the weight-loss drug market intensifies with Novo Nordisk and others.","why":"Investors are closely following Eli Lilly's obesity drug pipeline as the weight-loss medicine market booms.","tone":"positive","entities":["Eli Lilly","Retatrutide","Novo Nordisk"],"summarized_at":"2026-09-27T09:58:45.642970Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"Stocktwits","generic":0.05,"published":"Sat, 26 Sep 2026 23:43:14 GMT"},"nw":0.77,"promo":0.04,"kind":"news_event","importance":1.95,"hidden":false,"hide_reason":null,"judged_at":"2026-09-27T09:56:46.970591Z","title_en":"Eli Lilly CEO Pins Growth Hopes On Retatrutide","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-09-27T09:56:46.513038Z","rank":16,"volume":null},{"captured_at":"2026-09-27T11:18:45.470325Z","rank":20,"volume":null},{"captured_at":"2026-09-27T12:40:46.043478Z","rank":25,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNQ2YwUXdHYjhqV2hkZFBKTFhDSk9BOVlLTXBBSXpKRU8wZndKb0ZkcGIzMTN4ckdoQWJnS282MHRNS1NLdFhBVHB5TVZXU0FEa3QzemFDNzNXNEozZnkzbUtnbDRVNFBuSkI0WDUxbU1GYWx6YVdENXN3aWZyeGVVcno1dWx2WVNlcVEtUGVvVng4Y3ZxSmprZ2xBRnltRFg2MlFuREFHeFZLYUl2Y0g2WHlFcHdmNk90UjM1bGhlNmlVcGJTTTZ5eWlPSFdJNVVxZHY2b3A0Z28tOGdNVUF3SnBhZ1ZGMUxBS2N1R05yc1ZHM0w2UndTYUpUNG5LNUUtbzdjb3lTM0ZlQWh3RGc?oc=5","author":"stocktwits.com","title":"Eli Lilly CEO Bets On Weight-Loss Medicine Retatrutide As Next Growth Driver, Says Firm’s Future Has ‘Never Been Brighter’","snippet":null,"posted_at":"2026-09-26T23:43:14Z","likes":null}],"elsewhere":[],"window":"7d"}}